Patents by Inventor Jim Lorens

Jim Lorens has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD
    Publication number: 20200072839
    Abstract: The use of Akt3 as a biomarker for detecting the occurrence of epithelial-to-mesenchymal transition (EMT) in a subject, and the use of Akt3 inhibitors to treat cancer is disclosed herein. Also disclosed are various methods for detecting the occurrence of epithelial-to-mesenchymal transition (EMT) in a subject by measuring Akt3 expression and/or activity.
    Type: Application
    Filed: May 10, 2019
    Publication date: March 5, 2020
    Applicant: BERGENBIO ASA
    Inventors: Jim Lorens, Crina Tiron
  • Methods of detecting Akt3 and administering Ax1 inhibitor
    Patent number: 10317405
    Abstract: The use of Akt3 as a biomarker for detecting the occurrence of epithelial-to-mesenchymal transition (EMT) in a subject, and the use of Akt3 inhibitors to treat cancer is disclosed herein. Also disclosed are various methods for detecting the occurrence of epithelial-to-mesenchymal transition (EMT) in a subject by measuring Akt3 expression and/or activity.
    Type: Grant
    Filed: May 2, 2013
    Date of Patent: June 11, 2019
    Assignee: BERGENBIO ASA
    Inventors: Jim Lorens, Crina Tiron
  • METHOD
    Publication number: 20150119475
    Abstract: The use of Akt3 as a biomarker for detecting the occurrence of epithelial-to-mesenchymal transition (EMT) in a subject, and the use of Akt3 inhibitors to treat cancer is disclosed herein. Also disclosed are various methods for detecting the occurrence of epithelial-to-mesenchymal transition (EMT) in a subject by measuring Akt3 expression and/or activity.
    Type: Application
    Filed: May 2, 2013
    Publication date: April 30, 2015
    Inventors: Jim Lorens, Crina Tiron